plenty of good hcv drugs in devt...
by big names with plenty of cash...
HCV Treatment Studies at AASLD: Wow ... and I Mean WOW!
I didn't attend "The Liver Meeting" (the nickname for the annual meeting of the American Association for the Study of Liver Diseases, AASLD), but the studies presented there this week on HCV treatment were absolutely mind-boggling.
"Breathtaking!" said one of my HCV-oriented colleagues. "Hopeful is an understatement," said another.
...
But there's plenty more. Don't take my word for it -- go over to NATAP, click on the "Hepatitis C" link on the left, and start reading.
And if you have limited time, and want a glimpse of the future of HCV therapy, limit your search to studies that say "interferon-free".
http://www.thebodypro.com/content/64702/hcv-treatment-studies-at-aasld-wow-and-i-mean-wow.html?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+HIVCareToday+%28HIV+Care+Today%29
http://natap.org/
- Forums
- ASX - By Stock
- BIT
- pharmasset is on a roll offers 100% cure rate
pharmasset is on a roll offers 100% cure rate, page-29
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $17.14M |
Open | High | Low | Value | Volume |
2.0¢ | 2.1¢ | 1.9¢ | $6.308K | 311.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 1673695 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.1¢ | 93000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 1673695 | 0.019 |
12 | 2330053 | 0.018 |
5 | 688000 | 0.017 |
12 | 1556225 | 0.016 |
6 | 745000 | 0.015 |
Price($) | Vol. | No. |
---|---|---|
0.021 | 93000 | 2 |
0.022 | 200000 | 1 |
0.023 | 307000 | 2 |
0.024 | 255035 | 3 |
0.025 | 600000 | 3 |
Last trade - 15.39pm 08/11/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online